Nebraska Physician Appointed to Position at Mayo Clinic in Rochester
                   
pr.com     May 1, 2008          

Dr. Scott P. Liggett, M.D. recently accepted an appointment to join the internationally renowned medical practice and staff at Mayo Clinic at Rochester. “I am truly honored and flattered to be invited to practice medicine at such a credible institution,” says Liggett. “To work among the best of... [read full story]                    


View all news articles about*:
Internal Medicine Nephrology Pharmaceuticals
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

'Protein Complementarity' May Offer New Insights Into Autoimmune Diseases

drugs.com     Aug 18, 2008          

Antibodies against Plasminogen Linked to Blood Clots in Patients with ANCA Vasculitis WASHINGTON, Aug. 12, 2008 — The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused...                    

comments

                   

Versant(R) Leads New Era of Nursing Analytics, Accelerating Nursing Excellence from New Graduates

tmcnet.com     Aug 18, 2008          

LOS ANGELES --(Business Wire)-- In a continued effort to help hospitals retain quality, dedicated nurses and reduce new graduate turnover, Versant, developer of the Versant RN Residency, enters a new era of analytics designed...                    

comments

                   

Rituximab Promotes Healing in Common Kidney Disease

medicinenet.com     Aug 18, 2008          

FRIDAY, Aug. 15 (HealthDay News) -- The drug or a transplant. Rituximab may be able to heal the damage caused by membranous nephropathy in some patients, according to a new study. The drug, originally developed as a cancer...                    

comments

Bisphosphonate nephrotoxicity.

biowizard.com     Aug 17, 2008          

1Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA. Bisphosphonates are valuable agents for the treatment of post-menopausal osteoporosis (PMO), hypercalcemia of malignancy, and osteolytic...                    

comments